RxDoctor Payments Data

Hiram Cardona-Martinez, MD

Cardiology · Mayaguez, PRNPI 1528153855

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Boston Scientific at 35.6% of the total. Reporting peaked in 2019 at $767 and has fallen 73.4% since, to $204 in 2025.

$3,407in general payments, 2019–2025

Across 92 payments — averaging $37.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • AstraZeneca$379
  • Johnson & Johnson$281
  • Amgen$245
  • E.r. Squibb & Sons, L.L.C.$235
  • Medtronic$232
  • plus $823 from 8 others

What the payments were for

  • Food & beverage$3,37999%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific29$1,213
AstraZeneca16$379
Johnson & Johnson6$281
Amgen5$245
E.r. Squibb & Sons, L.L.C.5$235
Medtronic(2 entities)4$232
PBG Puerto Rico LLC14$228
Pfizer Pharmaceuticals LLC3$153
Boehringer Ingelheim3$130
Pfizer2$92
Abbott1$91
Merck2$79
Edwards Lifesciences1$29
Bayer1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few cardiology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$16,868
Medicare patients
87
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban93$89,932
XareltoRivaroxaban75$68,565
Repatha SureclickEvolocumab56$50,609
FarxigaDapagliflozin Propanediol41$42,159
Candesartan Cilexetil114$15,502
Candesartan-HydrochlorothiazidCandesartan/Hydrochlorothiazid30$5,392
Doxazosin Mesylate182$4,672
Rosuvastatin Calcium280$4,284
SynthroidLevothyroxine Sodium29$3,434
Metoprolol Succinate171$3,299
Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide61$2,596
Irbesartan58$2,222
Losartan Potassium161$2,027
Acebutolol Hcl28$1,941
Atorvastatin Calcium169$1,850

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$92$89,93293 claims
Johnson & JohnsonXarelto$281$68,56575 claims
AstraZenecaFarxiga$379$42,15941 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few cardiology providers in Puerto Ricoon file to place this against a meaningful peer group, so we don't.

Other cardiology in Mayaguez

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →